Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A study will be conducted to demonstrate that DRISTi will correctly diagnose Diabetic Retinopathy (e.g., mtmDR, PDR, DME) in eyes of patients with diabetes. Participants who have been diagnosed with diabetes mellitus and meet the other inclusion/exclusion criteria will be invited to participate and will consent to have ophthalmic images taken. These images will be analyzed by DRISTi AI software and evaluated by an ophthalmic reading center. The results will be compared, and a statistical analysis will be completed to ensure statistical significance in the outcomes thus proving DRISTi is an effective DR diagnosis tool.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Fundus Image Grading | Diagnostic Test | The image is graded by a fully automated AI device |
| Measure | Description | Time Frame |
|---|---|---|
| Accuracy of AI Grade | AI generated image grades are directly compared to a Human generated image grade | From time of arrival to completion of diagnostic tests, up to 8 hours |
Not provided
Not provided
Inclusion Criteria:
Ability to sign and date the informed consent form
Stated willingness to comply with all study procedures and availability for the duration of the study
Age (≥)21 years of age or older
Diagnosed with diabetes mellitus as per criteria established by the World Health Organization (WHO) or the American Diabetes Association (ADA)
Exclusion Criteria:
Persistent visual impairment in one or both eyes;
History of macular edema or retinal vascular (vein or artery) occlusion;
History of ocular injections, laser treatment of the retina, or intraocular surgery other than cataract surgery without complications;
Subject is contraindicated for fundus photography (for example, has light sensitivity);
Subject has contraindications for mydriatic medications or is unwilling or unable to dilate;
Subject is currently enrolled in an interventional study of an investigational device or drug for the same condition; or
Subject has a condition or is in a situation which in the opinion of the Investigator, might confound study results, may interfere significantly with the subject's participation in the study, or may result in ungradable clinical reference standard photographs
Subject falls into one of the below categories:
Not provided
Not provided
Not provided
Patients will be referred from primary care clinics and ophthalmology clinics in North Carolina.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Jeanne Champion, Primary Site Coordinator Oxford | Contact | 9192347003 | Jeanne@ncophth.com | |
| Adriana Valencia, Site Coordinator Raleigh | Contact | 9192347406 | Adriana@ncophth.com |
| Name | Affiliation | Role |
|---|---|---|
| Vinod Jindal, MD | New Century Ophthalmology | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| New Century Ophthalmology - Oxford | Recruiting | Oxford | North Carolina | 27565 | United States |
resource constraints
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003930 | Diabetic Retinopathy |
| D003920 | Diabetes Mellitus |
| ID | Term |
|---|---|
| D012164 | Retinal Diseases |
| D005128 | Eye Diseases |
| D003925 | Diabetic Angiopathies |
| D014652 | Vascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| New Century Ophthalmology - Raleigh | Recruiting | Raleigh | North Carolina | 27617 | United States |
|
| D002318 |
| Cardiovascular Diseases |
| D048909 | Diabetes Complications |
| D004700 | Endocrine System Diseases |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |